In January 1998, 12 people with vision & courage established in Greece the subsidiary of Chiesi, an international group research-oriented in the areas of AIR/CARE/RARE. Chiesi Hellas has become a forward-looking company with strong presence in the local pharmamarket for its culture and governance (2023-24Top Employer, 2024Best Workplace, 2024Best Workplace4Women, 2024GPTW, 2024 Most Sustainable Companies in GR, 2021Prix Galien, BCorp since 2019).
Ipsen avec 5 700 collaborateurs dans le monde est un groupe biopharmaceutique de taille moyenne focalisé sur des médicaments innovants en Oncologie, Maladie Rare et Neurosciences. Ipsen qui commercialise plus de 20 médicaments dans plus de 115 pays est également présent en Santé Familiale. La R&D d’Ipsen est située au cœur de clusters mondiaux tels que Paris-Saclay, France ; Oxford, UK ; Cambridge, US et enfin Shanghai, Chine.
Since 1998, EG Stada Group operates in Italy with the aim of “Caring for People’s health as a trusted partner”. We are part of the STADA Group, a multinational pharmaceutical company founded in Dresden in 1895 by an Association of Pharmacists, which operates on consumer healthcare, generics, biosimilar and specialty products with commitment and dedication.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
ABB is a technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. The company’s solutions connect engineering know-how and software to optimize how things are manufactured, moved, powered and operated. Building on more than 140 years of excellence, ABB’s ~105,000 employees are committed to driving innovations that accelerate industrial transformation
En tant que leader mondial de la santé animale, Zoetis est animée par un objectif unique : nourrir notre monde et l’Humanité en faisant progresser les soins aux animaux. Depuis plus de 70 ans, Zoetis innove pour prédire, prévenir, détecter et traiter les maladies animales tout en soutenant les personnes qui élèvent et soignent des animaux dans le monde entier, qu’il s’agisse de vétérinaires, de propriétaires d’animaux de compagnie ou d’éleveurs.
Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date.
* The company description for this page is added by the organisation and is not written by Top Employers Institute.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. In Pakistan, GSK provides trusted quality medicines and vaccines to more than 200 million patients for over seven decades. We aspire to capitalize on our leadership position by growing our general medicines portfolio, introducing innovative therapies, and using digital solutions.
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
Boehringer Ingelheim has been committed to providing innovative treatments in Human and Animal Health for over 130 years. Boehringer Ingelheim is a family-owned, R&D-driven company and one of the top 20 pharmaceutical companies in the world. Our employees create value through innovation in Human Health, Animal Health and contract manufacturing of biopharmaceuticals.